- The MAHA Movement Loves Psychedelics. Should Wall Street? WSJ
- Psychedelic nasal spray shows promise against depression Financial Times
- atai Life Sciences and Beckley Psytech Announce Positive GlobeNewswire
- Latham & Watkins Advises atai Life Sciences on US$50 Million Private Placement Financing Latham & Watkins LLP
- atai and Beckley Psytech announce positive Phase 2b results for treatment-resistant depression Indian Pharma Post